Drugs / Bifidobacterium Infants
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05674864 Comparator | Jan → Aug 2023 | Helicobacter pylori infectious disease | Tanta University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifidobacterium Infants | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05674864 ↗ |
| Modality | Other / unclassified | “probiotics (Bifidobacterium Infants, Enterococcus Feacium, and Lactobacillus Acidophilus)” NCT05674864 ↗ |